The Patient Capital consultation has generally been positively received. It contains a lot of high quality information and interesting research, and asks many pertinent questions as it seeks to inform policymaking designed to strengthen the UK’s ability to provide long-term capital to innovative, high growth businesses.
Back in the cold days of February, HM Treasury (HMT) announced it would be launching a Patient Capital Review with the objective of “strengthening the UK as a place for growing innovative firms to obtain the long-term ‘patient’ finance that they need to scale up”.
Are the Enterprise Investment Scheme and Seed Enterprise Investment Scheme set for a makeover? If the Conservative’s election manifesto is to be believed, they might be.
Welcome to the first edition of ZeitgEISt, giving you news, opinion and thought leadership from within the EIS and SEIS industry. Read ZeitgEISt here
Can EIS be patient? As my email to EISA members immediately following the Budget noted, the Chancellor and Treasury have confirmed that the Patient Capital Review will cover all existing tax reliefs that are aimed at encouraging investments and entrepreneurship, so will include EIS, SEIS […]
Influential committee of MPs heaps praise on Enterprise Investment Scheme but urges government to do more to promote it
A major part of EISA’s remit is to promote the Enterprise Investment Scheme (EIS) and Seed Enterprise Investment Scheme – their benefits to businesses that require funding and to the investors who provide the funding.
Over the past five years, the UK has become one of the best places in the world to start and grow a business. The Global Entrepreneurship Monitor puts the UK at number one in Europe and number four globally. This has been enabled by the […]
This has been an unusual summer. For many of us, the common tendency to relax, take our feet off the pedals and enjoy a well-deserved break has been at least partly offset by the vote for ‘Brexit’. This has cast a long and distracting shadow […]